Oren Hershkovitz is the CEO of Enlivex Therapeutics, a clinical-stage immunotherapy company. Based in Rehovot, Israel.
Oren Hershkovitz is the CEO of Enlivex Therapeutics, a clinical-stage immunotherapy company. The company focuses on developing an allogeneic drug pipeline for immune system rebalancing, utilizing its universal cell therapy, Allocetra™, to reprogram macrophages.
Full founder directory · Investor directory · Company funding database · Fundraising library